Animal feeds comprising yeast glucan
Abstract
A composition and a process for enhancing animal growth by orally administering the animal with the composition are provided. The composition comprises an animal feed and a yeast glucan wherein the animal feed can contain at least one starch-bearing substance such as, for example, grain meal; at least one protein-bearing substance such as, for example, fish meal; a fat-containing substance such as, for example, soybean oil; and the yeast glucan can be obtained from a yeast such as, for example, Saccharomyces cerevisiae.

Term
Term ended
Expired 20 July 2014, 12.2 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
7 claims: 2 independent, 5 dependent
- 1Use of an insoluble yeast cell wall material for increasing the growth performance of animals fed therewith wherein the cell wall material is substantially free of mannan, and phosphomannan or mannoprotein and having essentially no inherent nutritional value at the levels used.
- 2Use of an insoluble yeast cell wall material as claimed in Claim 1, wherein said yeast cell wall material is fed to said animal in combination with animal feed which comprises a starch-bearing substance selected from ground corn corn flour, oat flour, soybean flour, whole corn grain, whole wheat grain, wheat flour, and mixtures thereof;a protein-bearing substance selected from dry whey, fish meal, soybean meal, soybean protein concentrate, soy flour, blood meal, plasma protein, dried skim milk, whey protein concentrate, canola meal, corn gluten meal, wheat gluten meal, yeast, sunflower meal and mixtures thereof;a fat-containing substance selected from lard, tallow, soybean oil, lecithin, coconut oil, whey-fat blend and mixtures thereof;an antibiotic mix;and a vitamin-mineral mix wherein said cell wall material is selected from the group consisting of Saccharomyces cerevisiae, Saccharomyces uvarum, Candida utilis, Kluyveromyces fragilis, Pichia pastoris, and mixtures thereof.
- 3A composition comprising an animal feed and an insoluble yeast cell wall material substantially free of mannan, and phosphomannan or mannoprotein and having essentially no inherent nutritional value at the levels employed wherein said animal feed comprises a starch-bearing substance selected from the group consisting of ground corn corn flour, oat flour, soybean flour, whole corn grain, whole wheat grain, wheat flour, and mixtures thereof;a protein-bearing substance selected from the group consisting of dry whey, fish meal, soybean meal, soybean protein concentrate, soy flour, blood meal, plasma protein, dried skim milk, whey protein concentrate, canola meal, corn gluten meal, wheat gluten meal, yeast, sunflower meal and mixtures thereof;a fat-containing substance selected from the group consisting of lard, tallow, soybean oil, lecithin, coconut oil, whey-fat blend and mixtures thereof;an antibiotic mix;a vitamin-mineral mix;and wherein said insoluble yeast cell wall material is derived from yeast selected from the group consisting of Saccharomyces cerevisiae, Saccharomyces uvarum, Candida utilis, Kluyveromyces fragilis, Pichia pastoris , and mixtures thereof.
- 4The composition of Claim 3, characterized in that said starch-bearing substance is selected from the group consisting of ground corn, oat flour, oat groat, soybean flour, and mixtures thereof;said protein-bearing substance is selected from the group consisting of fish meal, soybean meal, and mixtures thereof;said fat-containing substance is whey-fat blend;and said yeast glucan is derived from Saccharomyces ceresvisiae .
- 5The composition of Claim 3, characterized in that said animal feed comprises 0.001% to 30% ground oat flour, 0.001% to 30% oat groats, 0.001% to 70% ground corn, 0.001% to 15% fish meal, 0.001 to 40% soybean meal, 0.01% to 8% ground soybean hulls, 0.001%. to 40% dried whey, 0.1% to 40% wheat middlings, 0.001% to 30% whey-fat blend, 0.001% to 5% dicalcium phosphate, 0.001% to 4% calcium carbonate, 0.001% to 4% fumaric acid, 0.001% to 3% antibiotic mix, 0.001 to 1% butter, 0.001% to 1% maple flavor, 0.001% to 1% lysine HC1, and 0.001% to 2% vitamin mineral mix, and said yeast glucan is present in the range of from 200g to 1500g per ton of said composition;wherein the % is weight % based on total weight % of said composition being 100%, said antibiotic mix comprises 100g of chlorotetracycline, 100g of sulfamethazine, and 50g of penicillin per ton of said composition;and said vitamin-mineral mix comprises copper sulfate;choline, selenium, vitamin E, biotin, folic acid, glycine, and ethoxyquin.
- 6The composition of Claim 3, characterized in that the weight % of starch-bearing substance is in the range of from about 10% to about 80%;the weight % of protein-bearing substance is in the range of from about 10% to about 50%;the weight % of said fat-containing substance is in the range of from about 2% to 15%;and said yeast glucan is in the range of about 50g to about 2500g per ton of said composition.
- 7The composition of Claim 3, characterized in that the weight of % of said starch-bearing substance is in the range of from 20% to 40%;the weight % of said protein-bearing substance is in the range of from 18% to 30%;the weight % of said fat-bearing substance is in the range of from 6% to 12%;and said yeast glucan is present in the range of from 200g to 1500g per ton of said composition.
Independent claims7
75 paragraphs, as filed
Field of the Invention
0001This invention relates to an animal feed composition that comprises yeast glucan and a process for enhancing animal growth by feeding animals with the feed composition.
Background of the Invention
0002European Patent Publication 466037 (Phillips Petroleum Company) describes administration of a yeast glucan to aquatic animals.
0003U.S. Patent 4,962,096 (Jamas et al.) describes liquid feeds for animals comprising glucan.
0004Neither of these references indicates that yeast cell wall material lacking particular materials can have an effect of improving feed uptake for animals nor any indication of the use of purified cell wall material such as glucan in any solid feed for terrestrial animals.
0005Limited supply of conventional food protein is a major problem facing a rapid increase in world population. Of particular importance is the production of animal proteins that contain proteins having essential amino acids required by humans. Due to limited production facilities and lack of improvement in production technology, increase in animal protein production does not seem to proportionate the increase in world population.
0006Therefore, it appears highly desirable to improve the productivity of animal protein production. One of the means to improve the productivity is to develop feed compositions that enhance animal growth.
Summary of the Invention
0007An object of the invention is to provide an animal feed composition. Another object of the invention is to provide a feed composition that would enhance animal growth. A further object of the invention is to provide a process for enhancing animal growth by feeding the animal with the feed composition. Other objects, features and advantages of the invention will become apparent as the invention is more fully disclosed hereinbelow.
0008According to a first embodiment of the invention, an animal feed composition that enhances animal growth is provided which comprises at least one starch-bearing substance, at least one protein-bearing substance, at least one fat-containing substance, and a yeast glucan.
0009According to a second embodiment of the invention, a process for enhancing animal growth is provided which comprises feeding a composition comprising at least one starch-bearing substance, at least one protein-bearing substance, at least one fat-containing substance, and a yeast glucan to an animal.
0010According to a third embodiment of the present invention, a composition is provided that can enhance the growth rate of an animal if the composition is orally administered to the animal. The composition comprises an animal feed and a yeast glucan. The yeast glucan is present in the composition in an amount sufficient to effect the growth enhancement.
0011According to a fourth embodiment of the present invention, a process for enhancing the growth of an animal is provided which comprises orally administering the composition which comprises an animal feed and a yeast glucan to an animal.
Detailed Description of the Invention
0012According to the first embodiment of the present invention, any animals whose growth can be enhanced upon being fed with the composition of the invention can be employed in the present invention and can vary widely. The preferred animals are warm blood animals which include, but are not limited to, chickens, pigs, turkeys, and calves. The presently most preferred are newly weaned or hatched animals such as, for example, weanling pigs.
0013To enhance the growth, the length of time required for feeding the invention composition to the animal can vary widely depending on the type of animals. For example, for a weaning pig, it is preferred to feed it for about 7 to 40 days.
0014Suitable starch-bearing substances are those commonly used as feed components and are generally derived from grains selected from the group consisting of corn, soybean, wheat, sorghum, barley, oat, and mixtures thereof. Examples of suitable starch-bearing substances include, but are not limited to, corn flour, oat groat, ground corn, soybean flour, wheat flour, ground oat flour, wheat middlings, soybean meal, corn grit, and mixtures thereof. The presently preferred suitable starch-bearing substances are oat flour, ground corn, oat groat, wheat middlings, soybean meal, and mixtures thereof. These starch-bearing substances are commercially available.
0015A variety of protein-bearing substances can be used as a component of the invention composition as long as the protein-bearing substance can support the growth of an animal. The protein content of protein-bearing substances can vary over the range of from about 10 weight % to about 90%. For economical reasons, a crude protein-bearing substance such as, for example, a fish meal, dried whey, a soybean meal, and mixture thereof can be used. Other suitable protein-bearing substances include, but are not limited to, soybean protein concentrate, soy flour, blood meal, plasma protein, dried skim milk, whey protein concentrate, canola meal, corn gluten meal, wheat gluten meal, yeast, sunflower meal, and mixtures thereof. The presently preferred protein-bearing substances are fish meal, dried whey, blood meal, plasma protein and soybean meal. These protein-bearing substances are commercially available.
0016Any fat-containing substance that can support the growth of an animal can be used. Suitable fat-containing substances include, but are not limited to, lard, tallow, soybean oil, lecithin, coconut oil, whey-fat blend, and mixtures thereof. The presently preferred fat-containing substances are soybean oil, coconut oil, and lard.
0017The term "yeast glucan" is used in this application to refer generically, unless otherwise indicated, to an insoluble yeast cell wall material substantially free of mannan and phosphomannan or mannoprotein and has essentially no inherent nutritional value at the levels incorporated in the composition of the invention. Yeast glucan is mainly composed of a backbone chain of β(1-3) linked glucose units with a low degree of inter- and intra-molecular branching through β(1-6) linkages. A minor component that consists mainly of a highly branched β(1-6) linked glucan is closely associated with the main component and both comprise alkali-insoluble glucan fractions.
0018The yeast glucan used in the invention can contain a glucan content (β(1-3) and β(1-6) linkages measured as glucose) from about 40% to about 99%, a protein content from about 0.01% to about 50%, a lipid content from about 0.01 to about 50%, an ash content from about 0.01% to about 12%, and a solids content from about 10% to about 100%; preferably a glucan content from about 40% to about 90%, a protein content from about 0.05% to about 30%, a lipid content from about 0.05% to about 45%, an ash content from about 0.05% to about 10%, and a solids content from about 20% to about 99%; more preferably a glucan content from about 50% to about 90%, a protein content from about 0.1% to about 10%, a lipid content from about 0.1% to about 40%, an ash content from about 0.5% to about 8%, and a solids content from about 70% to about 98%; and most preferably a glucan content from 60% to 85%, a protein content from 1% to 8%, a lipid content from 1% to 35%, an ash content from 1% to 5%, and a solids content from 90% to 99%. The percentage disclosed in this application is weight percent.
0019The yeast glucan suitable for use in the invention can be derived from any yeast species. Preferably the yeast glucan is derived from a yeast selected from the group consisting of <u>Saccharomyces</u><u>cerevisiae,</u><u>Saccharomyces uvarum,</u><u>Candida</u><u>utilis,</u><u>Kluyvecomyces</u><u>fragilis, Pichia</u><u>pastoris</u>, and combinations thereof. The presently preferred yeast species are <u>Saccharomyces</u><u>cerevisiae</u> and <u>Candida</u><u>utilis</u> because both have been traditionally and are used for food and feed supplements.
0020Yeast glucan can be prepared from the above-described yeast by any known method in the art including, for example, treatment with heat, bases, acids, enzymes, solvents, or combinations thereof. The choice of a suitable method is generally a matter of preference to those skilled in the art.
0021The presently preferred process for the preparation of a yeast glucan comprises: (1) preparing a yeast suspension in an alkaline solution to form a mixture containing an insoluble yeast cell wall fraction; (2) separating the insoluble yeast cell wall fraction from the mixture; (3) suspending the insoluble yeast cell wall fraction in an acid solution to form a yeast glucan; and (4) separating the yeast glucan.
0022The term "yeast suspension" used herein refers to, unless otherwise indicated, a liquid suspension of live yeast, inactive yeast, dried yeast, or combinations of two or more thereof.
0023According to the present invention, the yeast glucan can be prepared from a live yeast culture that is freshly grown, a yeast culture having a portion thereof that has lost viability (i.e., inactive yeast) a dried yeast, or combinations of two or more thereof. Processes for growing yeast or producing dried yeast are well known to those skilled in the art and are omitted here for the interest of brevity. A crude yeast glucan can also be prepared by any method known in the art including, for example, treatment with heat, bases, acids, enzymes, solvents, or combinations of two or more thereof. The choice of a suitable method for preparing the crude yeast glucan is generally a matter of preference to those skilled in the art.
0024Generally, a suspension of a yeast described above is prepared by addition of water to a concentration of from about 20 g/l to about 200 g/l, preferably from about 80 g/l to about 180 g/l, and most preferably from 100 g/l to 160 g/l. A basic compound in a solution then added to the suspension. The suspension can be mixed with any suitable means such as, for example, mechanical stirring with an agitator, to ensure a thorough distribution of the basic compound in the suspension. Alternatively, the yeast suspension can be added to the basic compound.
0025The basic compound used in the invention can be an organic base or an inorganic base and can be in either an aqueous or nonaqueous form. Generally the basic compound is substantially soluble in the suspension described above. The presently preferred basic compound is an inorganic base. Examples of suitable basic compounds include, but are not limited to, tetramethylammonium hydroxide, potassium hydroxide, sodium hydroxide, lithium hydroxide, magnesium hydroxide, calcium hydroxide, ammonium hydroxide, lithium carbonate, sodium carbonate, potassium carbonate, calcium carbonate, magnesium carbonate, and mixtures of two or more thereof. The presently most preferred basic compound is sodium hydroxide because of its availability and ease of use.
0026The amount of the basic compound required can vary widely, depending on the type of yeast or crude yeast glucan used. Generally, the basic compound is added to the above-described suspension such that the final concentration of the basic compound in the suspension is from about 0.01 M to about 6 M, preferably from about 0.1 M to about 3 M, and most preferably from 0.1 M to 2 M.
0027The mixture thus formed, containing the suspension, and the basic compound, is then subject to a treatment at a temperature of from about 20°C. to about 120°C. and preferably from about 20°C. to about 100°C. The time required for carrying out the process is generally in the range of from about 1/4 hours to about 24 hours and most preferably from 1/2 hour to 20 hours. The process of the invention can be carried out in a wide range of pressure from about 0.1 atmospheres (atm) to about 10 atm, preferably from about 0.5 atm to about 5 atm, and most preferably from 1 atm to 2 atm.
0028After the above-described treatment, a mixture containing an insoluble yeast cell wall fraction is formed. The insoluble fraction is separated from the soluble fraction by a separation means known to one skilled in the art such as, for example, centrifugation followed by, if desired, washing with water.
0029The insoluble cell wall fraction is then acidified with an acid. Any acid can be used. Presently, the preferred acid is a mild acid such as, for example, acetic acid. The insoluble cell wall fraction can be suspended in water followed by addition of an acid or suspended directly in an acid. The amount of acid required is the amount that is required to adjust the pH of the cell wall fraction to about pH7 or lower. The treatment of acid can be carried out under the same conditions as described above for the alkaline treatment. After the acid treatment, a yeast glucan is prepared.
0030The yeast glucan can be recovered by any suitable conventional means known to one skilled in the art such as, for example, centrifugation, filtration, decantation, and combinations thereof. The yeast glucan recovered can be further washed with a washing agent selected from the group consisting of water, acetone, methanol, ethanol, aqueous sodium chloride solution, diluted acetic acid solution, ether, hexane, and combinations of two or more thereof. The yeast glucan recovered can be resuspended in water or dried for use. Any conventional drying means such as, for example, spray drying, drum drying, freeze drying, air drying, and combinations thereof can be used to dry the yeast glucan product.
0031The composition of the invention can also comprise water- and fat-soluble vitamins and trace minerals. Suitable vitamins include vitamin A, vitamin D, vitamin E, vitamin K, riboflavin, pantothenic acid, niacin, vitamin B<sub>12</sub>, folic acid, biotin, vitamin C, and mixtures thereof. Suitable trace elements include copper, zinc, iodine, selenium, manganese, iron, cobalt, compounds thereof, or mixtures thereof. The term "trace" used herein denotes the quantity of these components used in the composition that is substantially smaller than that of other components. Generally the vitamins-trace minerals are present in the composition in the range of from about 0.0001 to about 5% based on total weight % of the composition.
0032According to the present invention, the composition can also contain an antioxidant such as, for example, ethoxyquin, BHT, BHA, vitamin E, ascorbic acid, and mixtures thereof. The composition can also contain an antibiotic mix such as, for example, chlorotetracycline, sulfamethazine, penicillin, and mixtures thereof. Generally very small quantity i.e., in the range of from about 0.0001 to about 1 weight %, of antioxidant or antibiotic is present in the composition.
0033The starch-bearing substance can be present in the composition in any concentration so long as it can effectively support the growth of an animal. The starch-bearing substance can be generally present in the composition in the range of from about 10 weight % to about 80 weight %, preferably about 15 weight % to about 50 weight %, and most preferably 20 weight % to 40 weight %.
0034Any concentration of protein-bearing substance can be employed as long as that concentration can effectively support the growth of an animal. Generally, the protein-bearing substance can be present in the composition in the range of from about 10 weight % to about 50 weight %, preferably about 15 weight % to about 40 weight %, and most preferably from 18 weight % to 30 weight %.
0035Similarly, any concentration of the fat-containing substance can be employed in the invention so long as that concentration can support the growth of the animal. The fat-containing substance generally can be present in the composition in the range of from about 2 weight % to about 20 weight %, preferably from about 4 weight % to about 15 weight %, and most preferably 6 weight % to 12 weight %.
0036The amount of the yeast glucan required in the composition is the amount that is required to increase the growth rate of an animal in the range of at least about 2%, preferably 4%, and most preferably 6%. The weight % of the yeast glucan present in the composition can generally be in the range of from about 0.001% to about 10%, preferably from about 0.01% to about 5%, and most preferably from 0.02% to 2%. The weight % of the vitamin-mineral mix described above can be present in the invention composition in the range of from about 0.0001% to about 5%, preferably about 0.001% to about 3%, and most preferably 0.01% to 2%.
0037All weight % disclosed herein is based on the total weight % of the composition equaling 100%.
0038In a preferred embodiment, an animal feed composition comprises 0.001% to 30% ground oat flour, 0.001% to 30% oat groats, 0.001% to 70% ground corn, 0.001% to 15% fish meal, 0.001% to 40% soybean meal, 0.001% to 8% ground soybean hulls, 0.001% to 40% dried whey, 0.1% to 40% wheat middlings, 0.001% to 30% whey-fat blend, 0.001% to 5% dicalcium phosphate, 0.001% to 4% calcium carbonate, 0.001% to 4% fumaric acid, 0.001% to 3% antibiotic mix, 0.001% to 1% butter, 0.001% to 1% maple flavor, 0.001% to 1% lysine HCl, and 0.001% to 2% vitamin-mineral mix; wherein the % is weight % based on total weight % of said composition being 100%; the antibiotic mix comprises 100 g of chlorotetracycline, 100 g of sulfamethazine, and 50 g of penicillin per ton of said composition; and the vitamin-mineral mix comprises copper sulfide, choline, selenium, vitamin E, biotin, folic acid, glycine, and ethoxyquin.
0039The composition is further illustrated in the feed diets disclosed in the Examples.
0040The composition of the first embodiment of the invention can be prepared by any mixing means known to one skilled in the art such as, for example, mechanical blending, extrusion, pelletizing, and spray drying. The order of adding individual components for mixing generally does not alter the physical characteristics or feeding efficiency of the composition. However, it is preferred that the yeast glucan be mixed with a carrier such as, for example, rice bran, grain, wheat bran, calcium carbonate, or mixtures thereof to facilitate even mixing and distribution. Any physical form of the composition such as, for example, powder, pellet, cube, semi-solid, and combinations thereof can be used.
0041According to the second embodiment of the invention, a process for enhancing animal growth is provided wherein the process comprises feeding an animal with an animal feed composition. The scope and preparation of the animal feed composition are the same as those described above in the first embodiment of the invention. The method for feeding the composition to animals are well known to one ordinarily skilled in the art. The choice of a specific delivery means is generally the preference of one skilled in the art. Specific methods for delivering the composition to animals are omitted for the interest of brevity.
0042According to the third embodiment of the present invention, a composition is provided which can be used to increase the growth rate of an animal by orally administering the composition to the animal. Any animal whose growth rate can be increased by at least about 2%, preferably about 4%, and most preferably 6%, upon being fed with the composition are suitable animals. Examples of such animals are the same as those disclosed in the first embodiment of the present invention.
0043According to the third embodiment of the present invention, any animal feed known to one skilled in the art or commercially available can be used in the present invention. Examples of suitable animal feeds generally contains a carbohydrate-containing substance, a protein-containing substance, and a lipid-containing substance; the scope and weight percent of which are the same as those disclosed above in the first embodiment of the present invention. A suitable animal feed can also contain water- and fat-soluble vitamins and trace minerals as well as antioxidant, scope and weight percent of these components are the same as those disclosed in the first embodiment of the invention.
0044The definition and scope of the yeast glucan are the same as those earlier disclosed in the first embodiment of the invention.
0045The concentration or amount of the yeast glucan in the composition is that concentration or amount that is sufficient to achieve a growth rate increase of at least about 2%, preferably about 4%, and most preferably 6% when an animal is fed with the composition. The presently preferred concentration is in the range of about 50 g to about 2,500 g, preferably about 100 g to about 2,000 g, and most preferably 200 g to 1,500 g of the yeast glucan per ton of the composition. The illustrative amount of the yeast glucan required to achieve the growth rate described above can also be expressed as unit weight per animal per day such as, for example, about 100 mg to 450 mg, preferably about 150 mg to about 400 mg, and most preferably 200 mg to 350 mg of yeast glucan per weanling pig per day.
0046The composition of the third embodiment of the present invention can be prepared by the same manner disclosed above in the first embodiment of the invention.
0047According to the fourth embodiment of the present invention, a process for enhancing the growth rate of an animal is provided which comprises orally administering an animal with a composition comprising an animal feed and a yeast glucan. The animal and the composition are the same as those disclosed above in the third embodiment of the invention. The time required to achieve the growth rate is the same as that disclosed in the second embodiment of the invention.
Example I
0048This example provides a general protocol used to obtain a yeast glucan suitable for the practice of the present invention.
0049Dry <u>Saccharomyces</u><u>cerevisiae</u> (500 g) was suspended in 3 liters of 6% aqueous NaOH solution. This suspension was then stirred overnight at room temperature. The suspension was then centrifuged at 2000 x g for 25 minutes. The supernatant was discarded and the insoluble residue was resuspended in 3 liters of 3% NaOH and incubated for 3 hours at 75°C. followed by cooling the suspension overnight. The suspension was then centrifuged at 2000 x g for 25 minutes and the supernatant was decanted.
0050The insoluble residue remaining was then adjusted to pH 4.5 with acetic acid. The insoluble residue was then washed with 2 liters of water three times and recovered by centrifuging at 2000 x g for 25 minutes after each wash (the supernatant was poured off). The residue was then suspended in 3 liters of a 0.5 M aqueous acetic acid. The suspension was heated for 3 hours at 90°C. The suspension was then cooled to room temperature. The insoluble residue was then collected by centrifuging at 2000 x g for 25 minutes.
0051The insoluble residue was then suspended in 3 liters of distilled water and stirred for 30 minutes at 100°C., then cooled and centrifuged at 2000 x g for 25 minutes. The. supernatant was discarded. The insoluble residue was spray dried and used in the following examples.
Example II
0052This example illustrates the effect of yeast glucan (β, 1-3 and 1-6 linkages) on enhancing growth of starter pigs.
0053A randomized, complete-block experiment was designed to feed the invention composition to starter pig. The yeast glucan employed in this Example was obtained by the process described in Example I and had about 60 weight % glucan (measured as glucose unit), about 6% protein, about 14% lipids, about 9% ash, and about 8% moisture. Six levels of yeast glucan were fed in Stage I and II (0.0, 0.23, 0.45, 0.68, 0.9, and 1.13 kg/ton) (0.0, 0.5, 1.0, 1.5, 2.0 and 2.5 lbs/ton); the level expressed as 0.0 kg/ton (lb/ton) was control diet). Four or five weanling pigs (19-21 days of age) were placed in each pen and each dietary treatment was represented by six weight replicates. Diets were based on current high performance diet standards (Table I).
0054Stage I diets (Table I) were fed to weanling pigs from day 0 to 13 and were based on 1.25% available lysine, 13.8 x 10<sup>3</sup> kJ ME/kg (3300 kcal ME/kg) of diet and formulated to contain 16% edible dried whey, 5% select menhaden fish meal, 10% oat flour and 10% oat groats.
0055Stage II diets were fed from day 14 to the end of the experiment (33 days) and were based on 1.15% available lysine, 13.4 x 10<sup>3</sup> kJ ME/kg (3200 kcal ME/kg) of diet and formulated to contain 6% edible dried whey, 3% select menhaden fish meal and 10% oat flour. Comparisons of feeding results were established using least-square means end linear, quadratic and cubic contrasts were tested in the statistical model. Pigs were weighed seven and thirteen days after the initiation of the experiment to better determine the effect of yeast glucan additions in Stage I growth.
0056The diet formulations are shown in Table I. <tables id="tabl0001" num="0001"><img file="EP0664671B1_D0001.tif" /></tables><tables id="tabl0002" num="0002"><img file="EP0664671B1_D0002.tif" /></tables>
0057The effect of the yeast glucan is shown in Table II. During the first seven days of Stage I, increasing the level of yeast glucan resulted in a quadratic change (P<.05) in feed intake (Table II). Pigs increased their intake in response to the increased concentration of dietary yeast glucan (from 0 to 0.45kg (1.0 1b) of yeast glucan/ton) but adding more glucan had little effect on intake. Daily gain followed the same pattern as feed intake. Adding more yeast glucan into starter diets during the last six days of Stage I resulted in linear decreases in daily gain (P<.02) and feed intake (P<.05). Table II shows that excellent optimal growth and feed intake were obtained when pigs were fed with 0.23 and 0.45 kg (0.5 and 1.0 pound) of yeast glucan/ton of feed, respectively. Table II further shows that starter pigs fed with 0.23 kg (0.5 pound) yeast glucan/ton grew 14.3% faster and were 8.7% more feed efficient than those with no added yeast glucan. The results in Table II also demonstrate that over the last 20 days of the experiment, daily gain (P<.07) and feed intake (P<.05) changed quadratically as more yeast glucan was added to the diets. Optimal levels of gain and feed intake over the last growth period were found in pigs fed with 0.23 kg (0.5 pound) of yeast glucan/ton of feed. Overall, growth performance of pigs changed quadratically as more yeast glucan was added to the diet. Table II indicates that performance was greatest at the lowest inclusion level of yeast glucan 0.23 kg/ton (0.5 lb/ton) and declined as dietary glucan increased. The results of this experiment demonstrated that yeast glucan improved growth rate and feed intake when fed at low levels. <tables id="tabl0003" num="0003"><img file="EP0664671B1_D0003.tif" /></tables><tables id="tabl0004" num="0004"><img file="EP0664671B1_D0004.tif" /></tables>
Example III
0058The effect of yeast glucan addition to animal feed was also tested with six additional randomized, complete-block experiments as described above. The animal feed compositions employed were the same as the stages I and II diets (Table I) containing 0.05 weight % of yeast glucan. The results shown in Table III demonstrate that addition of yeast glucan to animal feeds significantly improved the growth of weaned pigs (p<.05). The average results of the six tests indicate that yeast glucan increased daily gain 10.5% and the pigs were 1.3 Kg heavier at the end of the tests than those pigs which were not fed with feeds containing yeast glucan. Of particular interest was that there were no difference in efficiency of feed utilization for weight gain (see also Table II), indicating that the growth improvement was due solely to the presence of yeast glucan in the feed compositions. <tables id="tabl0005" num="0005"><img file="EP0664671B1_D0005.tif" /></tables>
Example IV
0059This example demonstrates that the growth enhancement of starter pigs fed with animal feed compositions containing yeast glucan was not due to antibacterial or antifungal effect of the yeast glucan.
0060The test was carried out the same as those described in Example II except that antibiotics were deleted as noted in Table IV. <tables id="tabl0006" num="0006"><table frame="all"><title>Table IV</title><tgroup cols="4" colsep="1" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><thead valign="top"><row rowsep="1"><entry namest="col1" nameend="col4" align="center">Effect of Yeast Glucan Addition to Animal Feed in Medicated Starter Pig Diets<sup>a</sup></entry></row></thead><tbody valign="top"><row><entry namest="col1" nameend="col1" align="left">Yeast Glucan, % of diet</entry><entry namest="col2" nameend="col2" align="right">0</entry><entry namest="col3" nameend="col3" align="right">.10</entry><entry namest="col4" nameend="col4" align="right">.10</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Medication<sup>b</sup></entry><entry namest="col2" nameend="col2" align="right">Added</entry><entry namest="col3" nameend="col3" align="right">None</entry><entry namest="col4" nameend="col4" align="right">Added</entry></row><row><entry namest="col1" nameend="col1" align="left">Final wt, Kg<sup>c</sup></entry><entry namest="col2" nameend="col2" align="right">18.42</entry><entry namest="col3" nameend="col3" align="right">17.83</entry><entry namest="col4" nameend="col4" align="right">19.23</entry></row><row><entry namest="col1" nameend="col1" align="left">Gain, Kg/day<sup>c</sup></entry><entry namest="col2" nameend="col2" align="right">.34</entry><entry namest="col3" nameend="col3" align="right">.33</entry><entry namest="col4" nameend="col4" align="right">.37</entry></row><row><entry namest="col1" nameend="col1" align="left">Feed intake, Kg/day<sup>c</sup></entry><entry namest="col2" nameend="col2" align="right">.48</entry><entry namest="col3" nameend="col3" align="right">.46</entry><entry namest="col4" nameend="col4" align="right">.52</entry></row><row rowsep="1"><entry namest="col1" nameend="col1" align="left">Feed:Gain</entry><entry namest="col2" nameend="col2" align="right">1.39</entry><entry namest="col3" nameend="col3" align="right">1.40</entry><entry namest="col4" nameend="col4" align="right">1.38</entry></row></tbody></tgroup><tgroup cols="4" colsep="0" rowsep="0"><colspec colnum="1" colname="col1" colwidth="39.37mm" /><colspec colnum="2" colname="col2" colwidth="39.37mm" /><colspec colnum="3" colname="col3" colwidth="39.37mm" /><colspec colnum="4" colname="col4" colwidth="39.37mm" /><tbody valign="top"><row><entry namest="col1" nameend="col4" align="justify"><sup>a</sup>6 pens per treatment</entry></row><row><entry namest="col1" nameend="col4" align="justify"><sup>b</sup>Medication contained 110 ppm sulfamethazine, 110 ppm of chlorotetracycline, and 55 ppm pf penicillin (by weight)</entry></row><row><entry namest="col1" nameend="col4" align="justify"><sup>c</sup>P<.05</entry></row></tbody></tgroup></table></tables>
0061Table IV shows that in the absence of medication, the weight gain decreased slightly from 0.34 Kg/day to 0.33 Kg/day, indicating medication played an important role in antibacterial or antifungal activity. When both yeast glucan and medication were included in the feed composition, the weight gain increased significantly from 0.34 Kg/day to 0.37 Kg/day, indicating that yeast glucan improved the growth rate of the animals. Table IV again shows that yeast glucan did not improve the feed efficiency, similar to those shown in Examples II and III.
Example V
0062This is a comparative example illustrating that a feed composition containing either autolyzed yeast or whole cell yeast did not enhance the growth of starter pigs.
0063The experiments were carried out as those described in Example I with the exception that yeast products as noted in Tables V and VI were included in the feed compositions shown in Table I. <tables id="tabl0007" num="0007"><img file="EP0664671B1_D0006.tif" /></tables>
0064Table V shows that simply feeding yeast cell walls or yeast cells did not improve the growth rate of animals. Wishing not to be bound by theory, it is believed that the upper digestive tract of the animals (i.e., stomach and small intestine) is not capable of removing the protein, fat, and other components of the yeast cell wall or yeast cells to expose the yeast glucan and, therefore, the animals are not capable of receiving the same benefit from yeast cell walls or yeast cells as from the yeast glucan. <tables id="tabl0008" num="0008"><img file="EP0664671B1_D0007.tif" /></tables><tables id="tabl0009" num="0009"><img file="EP0664671B1_D0008.tif" /></tables>
0065As shown in Table VI, daily gain, daily feed intake and efficiency of feed utilization were decreased by the addition of autolyzed and whole cell yeast products during Stage I. Furthermore, daily gain and feed intake were less effective by inclusion of autolyzed or whole cell yeast products in Stage II and starter pigs fed either 5.0% whole cell yeast or 5.0% autolyzed yeast had better efficiency when compared with 2.50% autolyzed yeast inclusion due to the nutritional factor contributed to these feed inclusion level. Moreover, Table VI also shows that adding glucan to the diet improved daily gain and efficiency of feed utilization when compared with control.
0066The results shown in the above examples clearly demonstrate that the present invention is well adapted to carry out the objects and attain the end and advantages mentioned as well as those inherent therein.
8 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US10293006B2 | Cited by | United States of America | Applicant |
| DE102006046960A1 | Cited by | Germany | Search report |
| US10844419B2 | Cited by | United States of America | Applicant |
| US9938558B2 | Cited by | United States of America | Applicant |
| US11910809B2 | Cited by | United States of America | Applicant |
| US10966437B2 | Cited by | United States of America | Applicant |
| US12018313B2 | Cited by | United States of America | Applicant |
| US11871767B2 | Cited by | United States of America | Applicant |
| US11910808B2 | Cited by | United States of America | Applicant |
| US10851399B2 | Cited by | United States of America | Applicant |
| US11291219B2 | Cited by | United States of America | Applicant |
| US10645952B2 | Cited by | United States of America | Applicant |
| US10701955B2 | Cited by | United States of America | Applicant |
| US11891647B2 | Cited by | United States of America | Applicant |
| US11044924B2 | Cited by | United States of America | Applicant |
| US2021267249A1 | Cited by | United States of America | Search report |
| US9993507B2 | Cited by | United States of America | Applicant |
| EP0354199A | Cites | European Patent Office (EPO) | – |
| EP0466037A | Cites | European Patent Office (EPO) | – |
| GB1153118A | Cites | United Kingdom | – |
| US3856940A | Cites | United States of America | – |
| US4225584A | Cites | United States of America | – |
| US4704276A | Cites | United States of America | – |
| US4962094A | Cites | United States of America | – |
| US5085874A | Cites | United States of America | – |
| US5232732A | Cites | United States of America | – |
| US5294458A | Cites | United States of America | – |
| Journal of the Scientific Agricultural Society of Finland, Vol. 53, No. 1, issued 1981, M.L. SALO et al., "Nutritive Value of Growing Pigs of Pekilo Protein and Torula Yeast Grown in Spent Sulphite Liquour", pages 52-56. | Non-patent | – | – |
25 members in 13 offices
Priority claims3
| Document | Office | Kind | Date |
|---|---|---|---|
| 102935 | United States of America | – | |
| 10293593 | United States of America | A | |
| 9408152 | United States of America | W |
Members25
| Document | Office | Kind | |
|---|---|---|---|
| CA2145858A1 | Canada | A1 | |
| WO9504467A1 | World Intellectual Property Organization (WIPO) | A1 | |
| FI951615A | Finland | A | |
| NO951316D0 | Norway | D0 | |
| NO951316L | Norway | L | |
| HU9500996D0 | Hungary | D0 | |
| PL308293A1 | Poland | A1 | |
| EP0664671A1 | European Patent Office (EPO) | A1 | |
| EP0664671A4 | European Patent Office (EPO) | A4 | |
| HUT70567A | Hungary | A | |
| JPH08504600A | Japan | A | |
| PL177628B1 | Poland | B1 | |
| NO313172B1 | Norway | B1 | |
| EP0664671B1This record | European Patent Office (EPO) | B1 | |
| AT223655T | Austria | T | |
| ATE223655T1 | Austria | T1 | |
| DE69431342D1 | Germany | D1 | |
| DK0664671T3 | Denmark | T3 | |
| PT664671E | Portugal | E | |
| ES2182845T3 | Spain | T3 | |
| DE69431342T2 | Germany | T2 | |
| CA2145858C | Canada | C | |
| JP2008029361A | Japan | A | |
| JP4074659B2 | Japan | B2 | |
| FI120859B | Finland | B |
83 legal events, as 13 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Announcement of lapse in spainLapsedFD2A | FD2A | ES | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Annulment/lapse due to non-payment of fees, searched and examined patentLapsedMAXIMUM VALIDITY LIMIT REACHEDMM4A | MM4A | PT | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Notification of lapseLapsedST | ST | FR | |
| Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal feeWithdrawnR119 | R119 | DE | |
| Patent lapsedLapsedMM4A | MM4A | IE | |
| Lapse due to non-payment of feesLapsedML | ML | GR | |
| Gb: european patent ceased through non-payment of renewal feeCeasedGBPC | GBPC | EP | |
| Lapse because of not paying annual feesLapsedMM01 | MM01 | AT | |
| Ep patent has lapsedLapsedEUG | EUG | SE | |
| Patent ceasedCeasedPL | PL | CH | |
| Ep patent lapsedLapsedEBP | EBP | DK | |
| Lapsed because of non-payment of the annual feeLapsedV1 | V1 | NL | |
| Be: lapsedLapsedBERE | BERE | EP | |
| Annulment/lapse due to non-payment of fees, searched and examined patentLapsedLAPSE DUE TO NON-PAYMENT OF FEESMM4A | MM4A | PT | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Change of applicant/patenteeR081 | R081 | DE | |
| Change of representativeR082 | R082 | DE | |
| Change of representativeR082 | R082 | DE | |
| Assignments of patentsSD | SD | NL | |
| Patent reinstated in contracting state [announced from national office to epo]PGRI | PGRI | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Transmission of propertyTP | TP | FR | |
| Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)REGISTERED BETWEEN 20100930 AND 20101006732E | 732E | GB | |
| No opposition filedOpposition26N | 26N | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| Fr: translation filedET | ET | EP | |
| Definitive protectionFG2A | FG2A | ES | |
| Ep patent validated in greeceEP | EP | GR | |
| Translation is availableAVAILABILITY OF NATIONAL TRANSLATIONSC4A | SC4A | PT | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Corresponds to:REF | REF | EP | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| New agentNV | NV | CH | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| Corresponds to:REF | REF | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOS IGRAGRAH | GRAH | EP | |
| Despatch of communication of intention to grantORIGINAL CODE: EPIDOS AGRAGRAG | GRAG | EP | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| First examination report despatched17Q | 17Q | EP | |
| Request for examination filed17P | 17P | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Designated contracting statesAK | AK | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 0664671
- Application
- 949226336
Titles3
- German
- TIERFUTTER MIT HEFEGLUCAN
- English
- ANIMAL FEEDS COMPRISING YEAST GLUCAN
- French
- ALIMENTS POUR ANIMAUX COMPRENANT UN GLUCANE DE LEVURE
Classification
- CPC, 3
- A23K50/60
- A23K10/12
- A23K20/163
- IPC, 4
- A23K1 00
- A23K1 16
- A23K1 18
- A23L1 28
Designated states16
- Contracting states, 16
- Austria
- Belgium
- Switzerland
- Germany
- Denmark
- Spain
- France
- United Kingdom
- Greece
- Ireland
- Italy
- Liechtenstein
- Monaco
- Netherlands (Kingdom of the)
- Portugal
- Sweden